Pharmacists in Gramercy, LA Accepting Medicare
8 Pharmacists found. Showing 1 - 8
 Mr. Richard Jude Oubre, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1803 Highway 3125, Gramercy, LA 70052 Phone: 225-869-8695 |
Lyle Bulger, PHARMACIST Pharmacist - Nutrition Support Medicare: Not Enrolled in Medicare Practice Location: 1635 Hwy 3125, Gramercy, LA 70052 Phone: 225-869-3651 Fax: 225-968-8826 |
 Mrs. Susan Porteous Campbell Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1803 La Hwy 3125, Gramercy, LA 70052 Phone: 225-869-8695 |
Henry Hubert Cazentre, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 303 E. Main Street, Gramercy, LA 70052 Phone: 225-869-3651 Fax: 225-869-8826 |
Jeanne Bourque Maylon Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1635 Highway 3125, Gramercy, LA 70052 Phone: 225-869-3651 Fax: 225-869-8826 |
Minh Tran Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1803 Highway 3125, Gramercy, LA 70052 Phone: 504-237-3272 |
Mrs. Ashley Hines Cashio Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1803 La Hwy 3125, Gramercy, LA 70052 Phone: 225-869-8695 |
Mr. Jude F. Poche Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1803 La Hwy 3125, Gramercy, LA 70052 Phone: 225-869-8695 |
News Archive
Aldosterone antagonist therapy can be adopted for treating heart failure
Less than one-third of patients hospitalized for heart failure and participating in a quality improvement registry received a guideline-recommended treatment of heart failure, aldosterone antagonist therapy, according to a study in the October 21 issue of JAMA.
Perifosine holds promise as a single agent for relapsed/refractory Waldenstrom's Macroglobulinemia
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
FDA accepts Pfizer's filing for axitinib review for advanced renal cell carcinoma
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted Pfizer's filing for standard review of axitinib for patients with advanced renal cell carcinoma (RCC).
New project to help control jet noise in tactical aircraft
The deafening roar of supersonic aircraft can cause hearing damage to Sailors and Marines on flight decks, so the Office of Naval Research (ONR) is funding a new project to help reduce jet noise, officials announced April 12.
› Verified 4 days ago